Brief: Ensysce Biosciences Says On March 28, Filed Amendment to Certificate Of Incorporation To Effect 1-For-12 Reverse Stock Split Of Common Stock
March 30 (Reuters) - Ensysce Biosciences Inc ENSC.O :
* ENSYSCE BIOSCIENCES - ON MARCH 28, FILED AMENDMENT THIRD AMENDED CERTIFICATE OF
INCORPORATION TO
EFFECT 1-FOR-12 REVERSE STOCK SPLIT OF COMMON STOCK
* ENSYSCE BIOSCIENCES INC - REVERSE STOCK SPLIT WILL BE EFFECTIVE AS OF 12:01 AM ON MARCH
31, 2023
Source text - https://bit.ly/40IEW3M
Further company coverage: ENSC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ensysce Biosciences
See all newsEnsysce Biosciences Q2 net loss widens on higher R&D costs
Ensysce Biosciences Inc expected to post a loss of 50 cents a share - Earnings Preview
NASDAQ RESUMED AT 09:47 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:42 AM
Brief: Ensysce Biosciences Launches Formal Review Of Strategic Alternatives - SEC Filing